Acute Myeloid Leukemia

Stem cell transplantation feasible after arsenic trioxide therapy

Published in Blood Weekly, June 20th, 2002

by Michael Greer, senior medical writer - Hematopoietic stem cell transplantation is feasible for acute promyelocytic leukemia patients treated with arsenic trioxide, researchers in Italy report.

"Arsenic trioxide (ATO) has been reported to be a safe and effective treatment for relapsed acute promyelocytic leukemia (APL)," explained Dr. Franco Leoni and colleagues working at the Policlinico di Careggi in Florence.

Stem cell transplants can help keep APL patients successfully treated with ATO in remission, Leoni and coauthors found.

The researchers evaluated the safety and efficacy of ATO and stem cell transplantation in a group of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-06-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry